You read this week’s publication New Cannabis Ventures Weekly Newsletter we publish from October 2015. We no longer send them. By mail as before but we post this and all newsletters On our website hereA number
Friends,
The Cannabis Global stock index had a rough beginning until September. After 45.5% growth in August and increased by 54.2% after the end of the month, the figure decreased from 7.74 to 6.99 in just two days. The result is now only 1.6% per annum. The Great Cannabis Etf MSOS, which is 21.0%, decreased by 17.2% in late August.
Currently there are 23 shares in the Global Cannabis stock index, and they are now 39.2% now. The return frame is from -19.6% to + 186.0%.
There are more than doubled three shares in late June and 13 are two-digit winners. In the last 2nds of June, two shares that have been added to the index are double digit dismantling.
Leading three shares are Canadian LPs, and this newsletter has called the best two coats this year this year. Of course, I alerted here TILRAY is a dangerous stock On August 20, and while he fell a lot from his last peak, it is still higher than at that time (and it is dangerous to stay.)
Today I want to give some caution on some of these names and explain why I’m worried. I have written articles about some, looking for alpha, which are carbon (Tilre and farms), and I continue to be very negative on MSOS ETF (bad diversification). I will celebrate the shares that are in the Global Cannabis stock index, which depict me in alphabetical order.
Aurora Cannabis (ACB)I was closely following this one but it’s no longer on my focus list to 420 investors. The company exploded it in Canada’s adult market, but it has expanded internationally medical hemp. I don’t think the General Director has done a good job, and the shares that make up 15.4% a year as if they are not attractive.
Canopy growth (CGC): I’m closely following CGC and I have been very negative on it for a while. It has become exclusively cannabis, but it continues to harm its actions and fight with many debts. The share decreased by 49.1% to time, and I design it will post a new time low.
Glass Home Brands (Glasf)I don’t contain this one in my focus list, but I pay attention to it, because it is only three MSOS index. I like the CEO, but I think the stock is overestimated. Two investors have been supported who support the Fund very loudly. Glasf is 21.7% per annum.
Rhythm (force): This one, who was known as Agri, was difficult to start in September, but it is 23.0% per annum. I wrote about it before here and I’ve watched it even though it’s not in my focus list. I am interested, because the green thumb industry has such a large share. While I love the idea of haunting beverage-based drinks, the company has a lot of work to do to justify its mass assessment.
SNDL (SNDL): I don’t contain this one in my focus list, but I said to the CEO I like me. The company has what I consider bad MSOS, and it now trades on the value of a tangible book. It makes 40.5% a year.
TILRAY brands (TLRY): I started providing Tlry for a long time since I was not satisfied. I appreciate the better balance and likes what the company does with the drinks in the United States, but the fund, which now goes down by 10.9%, seems very expensive. Share-Count has exploded. One year from now on my target is essentially below if the shares trade and the company does not benefit from transformation.
Trulieve (TCNNF)To date, 44.7%, shares are cheaply designed with adjusted EBITDA. I think that the margins expected by analysts are too high, and I am very careful for Florida, where it is quite large. I also don’t like the balance sheet that has many tax liabilities. If 280E tax is clinging around, this one will fall sharply.
Village farms (VFF)Although it has fallen from the last peak, it still ends 234.6% a year. I think it’s a good company and looks like a transformation, but the fund looks ahead of her. The company could receive a medical cannabis license in Texas, but it may not be. I loved it under $ 1. While I don’t expect it to be a lot I think it could fall a lot.
I covered here just stocks that are in Cannabis Global Stock Index, although there are shares that are not in the indumin. I wrote about some of them while looking for Alpha and I recently parted the post in my blog some cannabis shares that refer to meA number
If I didn’t mention a share with me I don’t want readers to believe the name I like at the current price. My model portfolio has 19.3% cash in the 420 investors, which is about 20%, and positions in two Canadian LPS, two MSOS and three auxiliary names. I try to create a portfolio that has less flaws than Cannabis Global Stock Index.
Any trader or investor that counts 280e taxes can see this to happen. I don’t suppose that it will be, but luck for all those who bet it will be.
Frankly,
Alan
This week’s newsletter is sponsored by Paul. Sapperstein Co.
On September 16, community growth partners are auction in North Massachusetts, etc. All applications must be delivered online. Learn more About 219 points about the auction auction.
Interested parties can contact Michael Saperstein 617-227-6553 or email msaperstein@pesco.comA number
New hemp enterprises publish medicine articles, as well as exclusive news. Here is what we published this last week.
To get real-time updates as our Facebook page or follow Alan RationSharing a number and discover industry news along with supporters, the largest hemp group and entrepreneurs group ConnectionA number
Stay on top of some important communications of public companies by watching upcoming Cannabis Investor Calendar:A number
Based on the Houston, Alan cries out his experience as the founder of the online community 420 InvestorThe first and still the biggest decent diligent platform focused on the shares sold in the cannabis industry. Alan continues to find new ways to connect industry and facilitate its sustainable growth in the Canepuni community. Approximately New hemp enterprisesHe is responsible for content development and strategic alliances. Until the early 2013 focuses on the cannabis industry, Alan, who began his career in Wall Street, worked as more than two decades of research and portfolio. Article 650 of the Article 650 published in 2007 Looking for alphaWhere he has 70,000 followers, Alan is a frequent speaker for industry conferences and a Frequent source The media, including NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Ration | Facebook | Connection | Email
Hemp stocks, as measured by the Global Hemp Stock Index, were quite volatile in 2024 and then again in 2025 as well. The index fell 7.5% in December last year to close 15.2% lower for the year, and it was also a poor start to 2025. It hit a new all-time high of 4.97 on the last day of March, before falling back in early April. The index gained 11.5% in April, but ended the second quarter from there, closing at 5.02. Q3 was strong with increases in July and August, and September, which started with a pullback, ended with another increase before pulling back on the last day. The index ended September down just a little, before falling in October and even lower in November. It rose sharply in December, rising 8.4% to 6.59. While stocks rose, 13 of the index’s 28 names declined for the month.
After collapsing 21.8% in late 2024 to 6.88 in Q4, the index fell heavily in Q1 and then marginally in Q2. The global hemp stock index, which now has 28 members, fell 27% year-to-date in June. After a 53.0 percent rally in the third quarter, the index increased by 11.6 percent compared to last year. It fell 14.2% in the 4th quarter and was down 4.2% for the full year.
Since its peak in February 2021, the global hemp stock index is down 92.9% from a closing high of 92.48.
The 3 strongest names in December, each an MSO, are all up more than 58%;
Each of these stocks were significantly up year-over-year, and Q4 earnings were positive for Trulieve.
December’s 3 weakest names are all down more than 8%;
All of these stocks were down year-over-year, and Q4 was brutal for each.
The index has been recalculated as of the close of 12/31/31 and is based on data as of 12/23/23. For Q1, the index will have 27 names, down from 28 names, with three removals and two additions. AFCG, LIEN and SHFS are excluded from the index. Akanda (AKAN) and cbdMD (YCBD) are rejoining the index.
We will summarize the performance of the index again in a month. In April, we historically combined the two articles, and we update here the other indexes that New Cannabis Ventures continues to maintain: the American Cannabis Operator Index, the Ancillary Cannabis Index, and the Canadian Cannabis LP Index.
American Hemp Operator Index
ACOI rallied in December, rising 43.7% to 13.18. It rose 123.6% to 12.99 in the third quarter and ended the year up 57.7% year to date from 8.36. The large AdvisorShares Pure US Cannabis ETF ( MSOS ) was a big laggard, up 23.9%.
December’s strongest stock was Trulieve, which gained 61.2%. The weakest, Curaleaf (OTC: CURLF ) (TSX: CURA ), rose 10.4%.
In January, the index will have eleven members, with the additions of Ascend Wellness (OTC: AAWH ), Grown Rogue (GRUSF ), and Vireo Health (OTC: VREOF ).
Auxiliary cannabis index
Ancillary commodities rose 2.4% in December as the index reached 11.09. The index, which rose 14.5% to 12.72 in the third quarter, fell 12.8% in the fourth quarter. It decreased by 19.5% from 13.77 in 2025.
The strongest performing stock in December was NewLake Capital (OTC: NLCP ), which rose 24.1%. The weakest, Chicago Atlantic Real Estate Finance (NASDAQ: REFI ), fell 3.9%.
In January, the index will have the same eight members and two that are returning: iPower (NASDAQ: IPW ) and Chicago Atlantic BDC (NASDAQ: LIEN ).
Canadian Hemp LP Index
Canadian LPs rose 5.4% in December as the index fell to 59.01. The index, which increased by 78.4% in the third quarter, reaching 73.56. Declined 19.8% in Q4, but rose 17.8% in 2025 from 50.11.
The strongest Canadian LP in December was MTL Cannabis (CSE: MTL ), which jumped 62.5% after receiving a buy order. The weakest performer was Aurora Cannabis, down 10.3%.
In January, the index will have the same thirteen members.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
Statistics Canada released October retail sales for the country, with Cannabis sales decline from September levels, down 4.7% to C$451.7 million. This sequential decline was further reduced on a daily basis due to the higher number of days compared to the previous month. September, originally reported at C$475.0 million, was revised slightly lower to C$473.9 million. October sales fell 0.9% year-over-year, down from 8.3% in May, 7.5% in June and 6.2% in September. This was also below the 20.3% growth rate in August 2023 and equal to the previous lowest annual growth rate since the start of legalization, which was -0.9% in September 2024, and it was significantly down from the 9.1% growth in December. August’s record level was only 1.8% higher than last year’s index. Total sales are expected to grow 4.5% to C$5.39 billion in 2024 and 4.3% year-to-date in 2025.
An increase in the number of shops, as well as a fall in the prices of flowers that attract consumers from the illegal market, have boosted sales. In Ontario, the most populous province, sales rose 0.1% from September and 3% from a year ago. Alberta grew 5.5% from September and 4% from a year ago. British Columbia was down 55.0% from September, as it was down 54% from a year ago, while Quebec was up 8.8% from September and 31% from a year ago.
November sales data will be released on January 23.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
Statistics Canada released September retail sales for the country, with Cannabis sales are on the rise from August levels, down 1.4% to C$475.0 million. This sequential decline increased on a daily basis due to fewer days compared to the previous month. August, originally reported at C$498.7 million, was revised slightly higher to C$503.1 million. Sales rose 6.6% in September from a year earlier, up from 8.3% in May and 7.5% in June. This was also below the 20.3% growth rate in August 2023 and above the previous lowest annual growth since the start of legalization in September 2024 of -0.9%, and it was significantly down from the 9.1% growth in December. In August, the record growth was only 1.8% higher than the index of the previous year. Total sales grew by 4.5% to C$5.39 billion in 2024 and 4.9% year-to-date in 2025.
An increase in the number of shops, as well as a fall in the prices of flowers that attract consumers from the illegal market, have boosted sales. In Ontario, the most populous province, sales fell 5.0% from August and less than 1% from a year ago. Alberta was down 5.5% from August and 4% from a year ago. British Columbia was down 6.0% from August as it grew 1% a year ago, while Quebec was down 5.2% from August and up 48% from a year ago.
October sales data will be released on December 19.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
